Y, F., A, T., A, K., & M, O. (2026). Use of Glucarpidase for Methotrexate-Induced Nephrotoxicity During the Treatment of Primary Central Nervous System Lymphoma. Cureus, 18(1), e100718. https://doi.org/10.7759/cureus.100718
Chicago Style (17th ed.) CitationY, Fujiwara, Takaono A, Kitagawa A, and Okamoto M. "Use of Glucarpidase for Methotrexate-Induced Nephrotoxicity During the Treatment of Primary Central Nervous System Lymphoma." Cureus 18, no. 1 (2026): e100718. https://doi.org/10.7759/cureus.100718.
MLA (9th ed.) CitationY, Fujiwara, et al. "Use of Glucarpidase for Methotrexate-Induced Nephrotoxicity During the Treatment of Primary Central Nervous System Lymphoma." Cureus, vol. 18, no. 1, 2026, p. e100718, https://doi.org/10.7759/cureus.100718.